openChicago, IL

Hv1 in Pulmonary Hypertension

National Heart Lung and Blood Institute

Description

The development of pulmonary hypertension is associated with oxidative stress, endothelial dysfunction, and pulmonary vascular remodeling. Pulmonary vascular remodeling is involved in proliferation and phenotypic transformation of pulmonary endothelial cells and smooth muscle cells. And endothelial dysfunction influences endothelial cell proliferation, and differentiation, leading to endothelial apoptosis-resistant hyperproliferation underlying the pathogenesis of pulmonary hypertension. The voltage-gated proton channel Hv1 has been shown to promote the production of NADPH oxidase (NOX)-derived reactive oxygen species (ROS) and plays an essential role in the regulation of cell proliferation and apoptosis. Here we discovered that Hv1 was implicated in pulmonary hypertension. The expression of Hv1 was significantly upregulated in the lungs of multiple rodent models of pulmonary hypertension and pulmonary hypertension patients. Moreover, deficiency of Hv1 reduced pulmonary hypertension burden in mouse model of hypoxia-induced pulmonary hypertension. To explore the role of Hv1 in the pathogenesis of pulmonary hypertension, we will apply transgenic mice and complementary in vivo approaches to delineate the contributions of Hv1 to the development of pulmonary hypertension. We plan to examine the molecular mechanisms of Hv1-mediated pulmonary hypertension and determine how Hv1 regulates the progression of pulmonary hypertension. Additionally, the Hv1 blockers will be applied to assess the translational potential of targeting Hv1 for treatment of pulmonary hypertension. Project Number: 1R01HL174544-01A1 | Fiscal Year: 2025 | NIH Institute/Center: National Heart Lung and Blood Institute (NHLBI) | Principal Investigator: Liang Hong | Institution: UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL | Award Amount: $522,794 | Activity Code: R01 | Study Section: Pulmonary Vascular Disease and Physiology Study Section [PVP] View on NIH RePORTER: https://reporter.nih.gov/project-details/1R01HL17454401A1

Interested in this grant?

Sign up to get match scores, save grants, and start your application with AI-powered tools.

Start Free Trial

Grant Details

Funding Range

$522,794 - $522,794

Deadline

March 31, 2029

Geographic Scope

Chicago, IL

Status
open

External Links

View Original Listing

Want to see how well this grant matches your organization?

Get Your Match Score

Get personalized grant matches

Start your free trial to save opportunities, get AI-powered match scores, and manage your applications in one place.

Start Free Trial